Display options
Cite
Nickoloff BJ, Mitra RS, Riser BL, et al. Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am J Pathol. 1988;132(3):543-51
Nickoloff, B. J., Mitra, R. S., Riser, B. L., Dixit, V. M., & Varani, J. (1988). Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. The American journal of pathology, 132(3), 543-51.
Nickoloff, B J, et al. "Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors." The American journal of pathology vol. 132,3 (1988): 543-51.
Nickoloff BJ, Mitra RS, Riser BL, Dixit VM, Varani J. Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am J Pathol. 1988 Sep;132(3):543-51. PMID: 2458044; PMCID: PMC1880764.
Copy Download .nbib Format: NLM
Share it on

Am J Pathol. 1988 Sep;132(3):543-51.

Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors.

The American journal of pathology

B J Nickoloff, R S Mitra, B L Riser, V M Dixit, J Varani

Affiliations

  1. Department of Pathology, University of Michigan, Medical School, Ann Arbor 48109-0602.

PMID: 2458044 PMCID: PMC1880764
Free PMC Article

Abstract

Normal human epidermal keratinocytes (KC) grown under conditions that maintain the undifferentiated state are highly motile. Migration of these cells as measured in two different assays (migration out of an agarose drop explant, and into micropore filters in a modified Boyden chamber), is stimulated by fibronectin (FN) and to a lesser extent by thrombospondin (TSP). In contrast, laminin (LN) inhibits KC migration. Cultivation of the cells for 1 day under conditions that induce differentiation (ie, in the presence of 1.4 mM Ca2+) suppresses KC motility. A number of soluble growth modulating polypeptide factors also influence KC migration. Transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) stimulate KC motility. These factors simultaneously induce KC production of FN and a significant portion of the stimulated motility can be inhibited with antibodies to FN. EGF and somatomedin-C (SM-C), but not TGF-beta, also stimulate TSP production while EGF and SM-C (but not TGF-beta) induce KC proliferation. In contrast to these factors, interferon-gamma (INF-gamma) inhibits KC production of both FN and TSP and concomitantly inhibits both motility and proliferation. These data suggest that KC properties essential for normal wound healing (ie, motility and proliferation) are regulated by both extracellular matrix molecules and soluble peptide factors. Finally, these effects of various growth promoting and antiproliferative factors on KCs may, in part, be mediated through alteration in the endogenous production of extracellular matrix molecules by KCs.

Similar articles

Cited by

References

  1. Dev Biol. 1965 Dec;12(3):394-407 - PubMed
  2. J Clin Invest. 1988 May;81(5):1537-44 - PubMed
  3. Br J Dermatol. 1973 Mar;88(3):245-8 - PubMed
  4. Am J Pathol. 1978 Jan;90(1):159-72 - PubMed
  5. J Invest Dermatol. 1978 Aug;71(2):157-62 - PubMed
  6. J Biol Chem. 1979 Oct 10;254(19):9933-7 - PubMed
  7. Arch Dermatol Res. 1979 Aug;266(1):33-41 - PubMed
  8. Cell. 1980 Dec;22(3):719-26 - PubMed
  9. J Invest Dermatol. 1982 Nov;79(5):264-9 - PubMed
  10. Am J Pathol. 1983 Apr;111(1):27-34 - PubMed
  11. J Biol Chem. 1984 Aug 25;259(16):10100-5 - PubMed
  12. J Clin Invest. 1984 Sep;74(3):1112-6 - PubMed
  13. Lab Invest. 1984 Dec;51(6):697-701 - PubMed
  14. J Am Acad Dermatol. 1985 Feb;12(2 Pt 2):420-33 - PubMed
  15. J Invest Dermatol. 1985 Aug;85(2):125-30 - PubMed
  16. J Biol Chem. 1986 Feb 5;261(4):1962-8 - PubMed
  17. Cancer Res. 1986 Apr;46(4 Pt 2):2068-71 - PubMed
  18. J Biol Chem. 1986 Mar 25;261(9):4337-45 - PubMed
  19. Ultrastruct Pathol. 1986;10(1):17-21 - PubMed
  20. J Exp Med. 1986 May 1;163(5):1319-24 - PubMed
  21. Science. 1986 Aug 1;233(4763):532-4 - PubMed
  22. J Invest Dermatol. 1986 Mar;86(3):260-5 - PubMed
  23. Exp Cell Res. 1986 Dec;167(2):376-90 - PubMed
  24. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9050-4 - PubMed
  25. J Clin Invest. 1987 Apr;79(4):1254-8 - PubMed
  26. J Invest Dermatol. 1987 May;88(5):594-601 - PubMed
  27. Cell. 1987 Sep 25;50(7):1131-7 - PubMed
  28. Science. 1987 Sep 11;237(4820):1333-6 - PubMed
  29. J Invest Dermatol. 1987 Nov;89(5):513-7 - PubMed
  30. J Invest Dermatol. 1987 Dec;89(6):551-4 - PubMed
  31. J Cell Biol. 1987 Dec;105(6 Pt 2):3097-104 - PubMed
  32. J Cell Biol. 1968 Oct;39(1):135-51 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources